Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



WebMD Not a Sure Winner

Not much has changed from what Seth Jayson had to say about WebMD's (Nasdaq: HLTH  ) fourth-quarter results earlier this year. The company is still under investigation regarding accounting irregularities at a predecessor company. And the majority of its revenue gains came from the addition of new customers through its acquisitions, rather than stronger sales of its products.

For the first quarter, the company yesterday reported that revenue increased to $271.2 million from $221.5 million a year earlier. Net income turned to a profit of $5.7 million vs. a loss of $7.4 million a year earlier.

Of the company's $271.2 million in revenue, $163.8 million came from the sale of software services for managing the exchange of data. That's an increase of $48.3 million for the division over the prior quarter. But, of that increase, $39.8 million came from customers obtained in recent acquisitions. It's legitimate revenue, but it came with a purchase cost and it shows that without growth from acquisitions, the company's data-interchange services grew only by $8.5 million, or about 7%. That's a rather small increase given that it's the primary source of revenue for the company.

The lack of significant sales growth in the data-interchange market is in large part due to heavy competition from companies such as McKesson (NYSE: MCK  ) , NDCHealth (NYSE: NDC  ) , Per-Se Technologies (Nasdaq: PSTI  ) , Cerner (Nasdaq: CERN  ) , and Quality Systems (Nasdaq: QSII  ) .

There's only one glimmer of hope that the company's services might be in greater demand going forward. That stems from the fact that through the recession and the only recently starting-to-improve labor market, doctors' visits were down significantly because people lost their benefits and saw their co-payments go up. If the job market improves significantly over the next year, then the situation should improve. More business for doctors could mean more new practices and more sales for WebMD. But, that's probably not going to have a huge impact, and it's something that would happen over an extended period of time, like several years.

Quality Systems is one of Tom Gardner'sMotley Fool Stock Advisorrecommendations. You can sign up for six months, risk-free to learn more.

Fool contributor Mark Mahorney doesn't own shares of any companies mentioned.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 507561, ~/Articles/ArticleHandler.aspx, 6/24/2017 8:25:29 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 11 hours ago Sponsored by:
Change down DOW 21394.8 -2.5 0.0%
Change up S&P 500 2438.3 3.8 0.2%
Change up NASD 6265.2 28.6 0.5%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

6/23/2017 4:00 PM
CERN $68.32 Up +0.98 +1.46%
Cerner CAPS Rating: ****
HLTH.DL $0.00 Down +0.00 +0.00%
HLTH Corp CAPS Rating: ***
MCK $166.96 Up +1.39 +0.84%
McKesson CAPS Rating: *****
PSTI $1.39 Down +0.00 +0.00%
Pluristem Therapeu… CAPS Rating: *
QSII $17.37 Up +0.14 +0.81%
Quality Systems CAPS Rating: ***